Theragen Etex Co Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Theragen Etex Co Limited with three other
companies in this sector in South Korea:
JW Shinyak Corp
sales of 83.38 billion Korean Won [US$74.63 million]
Hanall Biopharma Company Limited
(82.88 billion Korean Won [US$74.18 million]
of which 100%
was Medicinals and Bontanicals), and
Dae Han New Pharm Co., Ltd.
(109.40 billion Korean Won [US$97.92 million]
During the year ended December of 2016, sales at
Theragen Etex Co Limited were 101.28 billion Korean Won (US$90.65 million).
increase of 2.4%
versus 2015, when the company's sales were 98.88 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2014, when Theragen Etex Co Limited
reported sales of 106.58 billion Korean Won.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Theragen Etex Co Limited had sales
of 96.25 billion Korean Won.